219 related articles for article (PubMed ID: 23165980)
1. Patterns of survival in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia: a population-based study of 1,555 patients diagnosed in Sweden from 1980 to 2005.
Kristinsson SY; Eloranta S; Dickman PW; Andersson TM; Turesson I; Landgren O; Björkholm M
Am J Hematol; 2013 Jan; 88(1):60-5. PubMed ID: 23165980
[TBL] [Abstract][Full Text] [Related]
2. Elevated risk of venous but not arterial thrombosis in Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.
Hultcrantz M; Pfeiffer RM; Björkholm M; Goldin LR; Turesson I; Schulman S; Landgren O; Kristinsson SY
J Thromb Haemost; 2014 Nov; 12(11):1816-21. PubMed ID: 25196979
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristic and outcome of lymphoplasmacytic lymphoma of non-Waldenstrom macroglobulinemia type: A Swedish lymphoma registry study.
Brandefors L; Sander B; Lundqvist K; Kimby E
Br J Haematol; 2022 Mar; 196(6):1362-1368. PubMed ID: 34959252
[TBL] [Abstract][Full Text] [Related]
4. Cause-specific mortality in individuals with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia, 2000-2016.
Dalal NH; Dores GM; Curtis RE; Linet MS; Morton LM
Br J Haematol; 2020 Jun; 189(6):1107-1118. PubMed ID: 32090327
[TBL] [Abstract][Full Text] [Related]
5. Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden.
Kristinsson SY; Björkholm M; Goldin LR; McMaster ML; Turesson I; Landgren O
Blood; 2008 Oct; 112(8):3052-6. PubMed ID: 18703425
[TBL] [Abstract][Full Text] [Related]
6. Diffuse large B-cell lymphoma occurring in patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Clinicopathologic features of 12 cases.
Lin P; Mansoor A; Bueso-Ramos C; Hao S; Lai R; Medeiros LJ
Am J Clin Pathol; 2003 Aug; 120(2):246-53. PubMed ID: 12931555
[TBL] [Abstract][Full Text] [Related]
7. Primary therapy and relative survival in patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia: a population-based study in the Netherlands, 1989-2018.
Amaador K; Kersten MJ; Visser O; Brink M; Posthuma EFM; Minnema MC; Vos JMI; Dinmohamed AG
Br J Haematol; 2022 Feb; 196(3):660-669. PubMed ID: 34605017
[TBL] [Abstract][Full Text] [Related]
8. Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or Waldenstrom macroglobulinemia.
Kristinsson SY; Koshiol J; Björkholm M; Goldin LR; McMaster ML; Turesson I; Landgren O
J Natl Cancer Inst; 2010 Apr; 102(8):557-67. PubMed ID: 20181958
[TBL] [Abstract][Full Text] [Related]
9. MYD88 mutant lymphoplasmacytic lymphoma/Waldenström macroglobulinemia has distinct clinical and pathological features as compared to its mutation negative counterpart.
Patkar N; Subramanian PG; Deshpande P; Ghodke K; Tembhare P; Mascarenhas R; Muranjan A; Chaudhary S; Bagal B; Gujral S; Sengar M; Menon H
Leuk Lymphoma; 2015 Feb; 56(2):420-5. PubMed ID: 24828863
[TBL] [Abstract][Full Text] [Related]
10. [Clinical features of 16 cases of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia].
Wang JJ; Jing HM; Shen HW; Xu JS; Li M; Gao ZF; Ke XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1494-8. PubMed ID: 21176358
[TBL] [Abstract][Full Text] [Related]
11. Survival in monoclonal gammopathy of undetermined significance and Waldenström macroglobulinemia.
Kristinsson SY; Björkholm M; Landgren O
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):187-90. PubMed ID: 23490991
[TBL] [Abstract][Full Text] [Related]
12. Results of a randomized trial of chlorambucil versus fludarabine for patients with untreated Waldenström macroglobulinemia, marginal zone lymphoma, or lymphoplasmacytic lymphoma.
Leblond V; Johnson S; Chevret S; Copplestone A; Rule S; Tournilhac O; Seymour JF; Patmore RD; Wright D; Morel P; Dilhuydy MS; Willoughby S; Dartigeas C; Malphettes M; Royer B; Ewings M; Pratt G; Lejeune J; Nguyen-Khac F; Choquet S; Owen RG
J Clin Oncol; 2013 Jan; 31(3):301-7. PubMed ID: 23233721
[TBL] [Abstract][Full Text] [Related]
13. Lymphoplasmacytic lymphoma-Waldenstrom's macroglobulinemia.
Vitolo U; Ferreri AJ; Montoto S
Crit Rev Oncol Hematol; 2008 Aug; 67(2):172-85. PubMed ID: 18499469
[TBL] [Abstract][Full Text] [Related]
14. Lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia: an evolving concept.
Lin P; Medeiros LJ
Adv Anat Pathol; 2005 Sep; 12(5):246-55. PubMed ID: 16210920
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors and primary treatment for Waldenström macroglobulinemia - a Swedish Lymphoma Registry study.
Brandefors L; Melin B; Lindh J; Lundqvist K; Kimby E
Br J Haematol; 2018 Nov; 183(4):564-577. PubMed ID: 30198549
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and biological characteristics of non-IgM lymphoplasmacytic lymphoma].
Yu Y; Xiong WJ; Chen JW; Jiao Y; Yan YT; Wang Q; Zou DH; Liu W; Liu HM; Lyu R; Qiu LG; Yi SH
Zhonghua Xue Ye Xue Za Zhi; 2022 Jul; 43(7):568-574. PubMed ID: 36709134
[No Abstract] [Full Text] [Related]
17. Nuclear protein dysregulation in lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia.
Roberts MJ; Chadburn A; Ma S; Hyjek E; Peterson LC
Am J Clin Pathol; 2013 Feb; 139(2):210-9. PubMed ID: 23355206
[TBL] [Abstract][Full Text] [Related]
18.
Luo Y; Cao X; Pan Q; Li J; Feng J; Li F
J Nucl Med; 2019 Dec; 60(12):1724-1729. PubMed ID: 31101745
[No Abstract] [Full Text] [Related]
19. Lymphoplasmacytic lymphoma and Waldenström macroglobulinemia.
Naderi N; Yang DT
Arch Pathol Lab Med; 2013 Apr; 137(4):580-5. PubMed ID: 23544948
[TBL] [Abstract][Full Text] [Related]
20. The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG).
Buske C; Hoster E; Dreyling M; Eimermacher H; Wandt H; Metzner B; Fuchs R; Bittenbring J; Woermann B; Hohloch K; Hess G; Ludwig WD; Schimke J; Schmitz S; Kneba M; Reiser M; Graeven U; Klapper W; Unterhalt M; Hiddemann W;
Leukemia; 2009 Jan; 23(1):153-61. PubMed ID: 18818699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
